• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Cosmetic Raw Material
  • Pharmaceutical IntermediatesPharmaceutical intermediates Nutritional Supplements Pharmaceutical raw materials
  • OEM & ODMCapsule Softgel Capsule Gummies Drop & drinks Tables
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Anthelmintics Antiviral drugs Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Pharmaceutical raw material Mupirocin Powder

    • Pharmaceutical raw material Mupirocin Powder
    • Pharmaceutical raw material Mupirocin Powder storehouse
    • Pharmaceutical raw material Mupirocin Powder quality testing
    • Pharmaceutical raw material Mupirocin Powder quality testing
    • Pharmaceutical raw material Mupirocin Powder certificate

    Product Overview:

    Mupirocin, also known as Pseudomonas aeruginosa A, is an ideal antibacterial agent for the skin surface, which was introduced to the market by GlaxoSmithKline in 1985 under the trade name of "Bactroban". The US FDA approved the use of this drug in the United States in 1987, and China approved the production and sale of this drug by CMS Pharmaceuticals in 1993. Mupirocin is mainly used for the prevention and treatment of bacterial skin infections caused by gram-positive cocci.

    Pharmaceutical raw material Mupirocin Powder Attributes

    Pharmaceutical raw material Mupirocin Powder

    CAS:12650-69-0

    MF: C26H44O9

    Mupirocin Raw Materials

    MW:500.62

    EINECS:603-145-3

    Specification​: 99% min Mupirocin Powder

    Sample:Mupirocin Powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Pharmaceutical raw material Mupirocin Powder Details

    Mupirocin Powder Usage and Synthesis.

    Mupirocin, also known as Pseudomonas aeruginosa A, is an ideal antibacterial agent for the skin surface, which was introduced to the market by GlaxoSmithKline in 1985 under the trade name of "Bactroban". The US FDA approved the use of this drug in the United States in 1987, and China approved the production and sale of this drug by CMS Pharmaceuticals in 1993. Mupirocin is mainly used for the prevention and treatment of bacterial skin infections caused by gram-positive cocci.

    Mupirocin Powder

    Uses and functions of Mupirocin.

    Topical antibiotic. Blocks isoleucine senescence by reversibly binding to isoleucine transfer RNA synthetase, thereby halting the synthesis of all isoleucine-containing proteins in the cell. Used for acute primary bacterial infections of the skin, such as folliculitis and impetigo.

    Generally used for dermatological aspects of inflammation, eczema, etc., made into commercially available mupirocin ointment

    Mupirocin is mainly used for the prevention and treatment of bacterial skin infections caused by gram-positive cocci, such as impetigo, boils, folliculitis and other primary skin infections, and eczema co-infections, ulcers co-infections, trauma co-infections and other secondary skin infections.

    The main mechanism of the antibacterial effect of mupirocin is to inhibit the protein synthesis in the body of bacteria.

    Mupirocin Raw Materials

    Pharmacological Effects Mupirocin.

    Mupirocin has strong antibacterial activity against a variety of Gram-positive cocci associated with skin infections and is also effective against drug-resistant Staphylococcus aureus. It has some antibacterial effect on certain Gram-negative bacteria. No cross-resistance with other antibiotics.

    Mupirocin Raw Powder

    Production method of Bulk Mupirocin Powder.

    A group of substances produced by Pseudomonas fluorescens, including Pseudomonas acids A, B, C and D, of which mupirocin is the main metabolite Pseudomonas acid A

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,